Literature DB >> 20704635

Distinguishing features of autism in boys with fragile X syndrome.

M Brock1, D Hatton.   

Abstract

BACKGROUND: Males with fragile X syndrome and autism (FXS/autism) represent a distinct subgroup of males with FXS at risk for markedly poorer outcomes. Early identification and intervention can improve outcomes for males with autism spectrum disorder.
METHOD: To advance the development of a specialised autism screening tool for young males with FXS that could assist in early identification, backward regression was used to identify the combination of parent-report questionnaire items that best predicted autism symptoms in a sample of 60 males with FXS, ages 4-18 years old.
RESULTS: Both social and repetitive behaviours distinguished males with FXS/autism, with repetitive behaviours playing a more prominent role than previously documented in the literature.
CONCLUSIONS: Healthcare workers and early interventionists may be able to interview parents about a few key behaviours to determine if young child with FXS should be formally evaluated for autism. Evidence-based practices identified for children with autism spectrum disorder can be implemented as early as possible.
© 2010 The Authors. Journal of Intellectual Disability Research © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20704635     DOI: 10.1111/j.1365-2788.2010.01315.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  17 in total

1.  Differential Relationships of Anxiety and Autism Symptoms on Social Skills in Young Boys With Fragile X Syndrome.

Authors:  Debra L Reisinger; Jane E Roberts
Journal:  Am J Intellect Dev Disabil       Date:  2017-09

2.  Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores.

Authors:  Andrea McDuffie; Angela John Thurman; Randi J Hagerman; Leonard Abbeduto
Journal:  J Autism Dev Disord       Date:  2015-07

Review 3.  Public Health Literature Review of Fragile X Syndrome.

Authors:  Melissa Raspa; Anne C Wheeler; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

Review 4.  Early identification of autism in fragile X syndrome: a review.

Authors:  L M McCary; J E Roberts
Journal:  J Intellect Disabil Res       Date:  2012-09-14

5.  DSM-5 changes and the prevalence of parent-reported autism spectrum symptoms in Fragile X syndrome.

Authors:  Anne C Wheeler; Joanna Mussey; Adrienne Villagomez; Ellen Bishop; Melissa Raspa; Anne Edwards; James Bodfish; Carla Bann; Donald B Bailey
Journal:  J Autism Dev Disord       Date:  2015-03

6.  The relationship between autistic symptomatology and independent living skills in adolescents and young adults with fragile X syndrome.

Authors:  Kristin M Hustyi; Scott S Hall; Eve-Marie Quintin; Lindsay C Chromik; Amy A Lightbody; Allan L Reiss
Journal:  J Autism Dev Disord       Date:  2015-06

7.  Outcome measures for clinical trials in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; David Hessl; Leonard Abbeduto; Allan L Reiss; Andrea Beckel-Mitchener; Tiina K Urv
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

8.  Impact of adherence to best practice guidelines on the diagnostic and assessment services for autism spectrum disorder.

Authors:  Claire Hathorn; Nahed Alateeqi; Catriona Graham; Anne O'Hare
Journal:  J Autism Dev Disord       Date:  2014-08

9.  Evidence of a distinct behavioral phenotype in young boys with fragile X syndrome and autism.

Authors:  Jason J Wolff; James W Bodfish; Heather C Hazlett; Amy A Lightbody; Allan L Reiss; Joseph Piven
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-12       Impact factor: 8.829

10.  Topological methods reveal high and low functioning neuro-phenotypes within fragile X syndrome.

Authors:  David Romano; Monica Nicolau; Eve-Marie Quintin; Paul K Mazaika; Amy A Lightbody; Heather Cody Hazlett; Joseph Piven; Gunnar Carlsson; Allan L Reiss
Journal:  Hum Brain Mapp       Date:  2014-04-15       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.